INTERNATIONAL PATENT: HANX BIOPHARMACEUTICALS, (WUHAN) LTD. FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATES TARGETING TRBV12 AND USES THEREOF"

GENEVA, Dec. 8 -- HANX BIOPHARMACEUTICALS, (WUHAN) LTD. (Building A8, BioPark IIJiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073) filed a patent application (PCT/CN2025/098022) for "ANTIBODY-DRUG CONJUGATES TARGETING TRBV12 AND USES THEREOF" on May 29, 2025. With publication no. WO/2025/247325, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KE, Hang (Building A8, BioPark II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073), YANG, Tao (Building A8, BioPark II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 4300...